V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 200006285 | 200017802 | 1.79 | 76.7 | Palliative (P) | 2018-08-12 | 2018-08-30 | IPILIMUMAB + NIVOLUMAB | 02 | N | IPILIMUMAB + NIVOLUMAB | 100382654 |
| 200006289 | 200017804 | 1.73 | null | null | 2019-06-26 | 2019-06-28 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 100482359 |
| 200006290 | 200017805 | null | 67 | Palliative (P) | 2020-05-21 | 2020-12-18 | DABRAFENIB | 02 | null | DABRAFENIB | 100977323 |
| 200006291 | 200017806 | 1.61 | 73 | Adjuvant (A) | 2019-12-10 | 2020-05-11 | Temozolomide 200mg/m2 | 01 | null | TRIAL UNSPECIFIED | 100857513 |
| 200006294 | 200017807 | null | null | null | null | 2021-09-10 | null | null | null | TALIMOGENE LAHERPAREPVEC | 100777524 |
| 200006296 | 200017808 | 1.72 | 69 | Palliative (P) | 2020-06-10 | 2020-06-10 | Trametinib | 02 | null | TRIAL UNSPECIFIED | 100441635 |
| 200006299 | 200017809 | 1.7 | 96 | Palliative (P) | 2022-05-05 | 2022-05-05 | null | 02 | N | DABRAFENIB | 100596271 |
| 200006300 | 200017810 | null | 49.55 | Palliative (P) | 2017-12-07 | 2017-12-20 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 100063766 |
| 200006307 | 200017812 | 1.75 | 45.2 | null | 2018-02-28 | 2018-03-14 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 101639873 |
| 200006311 | 200017815 | 1.64 | 69 | null | 2019-07-10 | 2019-07-28 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 100333840 |
| 200006312 | 200017816 | 1.64 | 50.3 | Neo-adjuvant (N) | 2021-04-05 | 2021-04-12 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 101190994 |
| 200006314 | 200017817 | 1.7 | 71.3 | Adjuvant (A) | 2020-01-03 | 2020-01-03 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 100952058 |
| 200006326 | 200017819 | 1.83 | 71.8 | Palliative (P) | 2021-09-26 | 2021-12-31 | null | 02 | null | DABRAFENIB | 101796085 |
| 200006338 | 200017823 | 1.67 | 92 | null | 2018-02-10 | 2018-02-13 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 100810821 |
| 200006343 | 200017825 | 1.7 | 105 | Palliative (P) | 2019-06-15 | 2019-06-22 | DABRAFENIB | 02 | null | DABRAFENIB | 100049485 |
| 200006346 | 200017826 | 1.85 | 87 | Disease modification (D) | 2019-10-03 | 2019-10-24 | BLEOMYCIN + CISPLATIN + ETOPOSIDE + METHOTREXATE + VINCRISTINE | 02 | null | IPILIMUMAB + NIVOLUMAB | 101185765 |
| 200006349 | 200017828 | 1.65 | 75.7 | Palliative (P) | 2021-08-17 | 2021-08-31 | null | 02 | null | IPILIMUMAB + NIVOLUMAB | 100173131 |
| 200006353 | 200017829 | 1.65 | 72.7 | Palliative (P) | null | 2019-01-26 | null | null | null | DACARBAZINE | 100418304 |
| 200006354 | 200017830 | 1.71 | 79 | Palliative (P) | null | 2020-10-29 | null | null | N | DACARBAZINE | 100576018 |
| 200006355 | 200017831 | null | 81.4 | 03 | null | 2021-04-19 | null | null | N | IPILIMUMAB + NIVOLUMAB | 100696584 |
| 200006364 | 200017834 | 1.8 | null | null | null | 2019-12-04 | null | null | null | IPILIMUMAB + NIVOLUMAB | 101645486 |
| 200006369 | 200017835 | null | null | null | null | 2019-11-11 | null | null | null | IPILIMUMAB + NIVOLUMAB | 100276210 |
| 200006373 | 200017836 | null | null | null | null | 2021-05-21 | null | null | null | COLUMBUS TRIAL | 100830368 |
| 200006376 | 200017838 | 1.88 | 0 | Palliative (P) | 2018-07-27 | 2018-08-10 | Ipilimumab | 02 | N | IPILIMUMAB | 101081559 |
| 200006377 | 200017839 | 1.92 | 75.9 | Palliative (P) | null | 2017-03-13 | null | null | N | IPILIMUMAB + NIVOLUMAB | 100965336 |
| 200006381 | 200017840 | null | null | null | 2017-12-29 | 2018-01-05 | null | N | null | IPILIMUMAB + NIVOLUMAB | 100040936 |
| 200006386 | 200017841 | 1.68 | 87.2 | Palliative (P) | null | 2019-04-21 | null | null | N | IPILIMUMAB | 101473146 |
| 200006388 | 200017842 | 1.63 | null | null | null | 2021-03-01 | null | null | null | IPILIMUMAB | 100790630 |
| 200006390 | 200017843 | null | null | null | null | 2018-03-11 | null | null | null | IPILIMUMAB + NIVOLUMAB | 101339222 |
| 200006392 | 200017844 | 1.6 | 119.4 | null | 2020-01-22 | 2020-01-23 | Ipilimumab | 02 | null | IPILIMUMAB | 100830163 |
| 200006397 | 200017847 | 1.62 | null | null | null | 2018-07-28 | null | null | null | TRIAL UNSPECIFIED | 101059769 |
| 200006402 | 200017849 | 1.82 | 87 | Palliative (P) | null | 2018-02-15 | null | null | null | BINIMETINIB + ENCORAFENIB | 100229565 |
| 200006415 | 200017852 | 1.8 | 61 | Palliative (P) | 2022-01-13 | 2022-02-06 | null | N | N | IPILIMUMAB + NIVOLUMAB | 100075272 |
| 200006430 | 200017855 | null | 59.9 | Palliative (P) | null | 2018-11-07 | null | null | N | CISPLATIN + DACARBAZINE | 100783109 |
| 200006431 | 200017856 | null | null | null | null | 2020-05-17 | null | null | null | IPILIMUMAB + NIVOLUMAB | 100573544 |
| 200006432 | 200017857 | 1.72 | null | null | null | 2017-08-31 | null | null | null | IPILIMUMAB + NIVOLUMAB | 100940869 |
| 200006435 | 200017858 | 1.6 | 68.2 | Palliative (P) | 2021-11-20 | 2021-11-21 | Ipilimumab | 02 | null | IPILIMUMAB | 101416584 |
| 200006438 | 200017859 | 1.83 | 67.25 | Palliative (P) | null | 2021-04-24 | null | null | N | IPILIMUMAB | 100161771 |
| 200006448 | 200017862 | null | null | null | null | 2017-04-26 | null | null | null | BLEOMYCIN | 101219397 |
| 200006452 | 200017864 | null | 75.3 | Palliative (P) | null | 2021-11-15 | null | null | null | DABRAFENIB | 100620057 |
| 200006453 | 200017865 | 1.66 | 108 | Palliative (P) | null | 2020-09-17 | null | null | N | BINIMETINIB + ENCORAFENIB | 100699383 |
| 200006456 | 200017866 | null | null | null | null | 2019-07-22 | null | null | null | IPILIMUMAB | 101531999 |
| 200006462 | 200017869 | null | null | null | null | 2020-06-11 | null | null | null | IPILIMUMAB + NIVOLUMAB | 100324638 |
| 200006465 | 200017870 | null | null | null | null | 2018-04-08 | null | null | null | TRIAL UNSPECIFIED | 100763139 |
| 200006470 | 200017872 | 1.71 | null | null | null | 2021-04-26 | null | null | null | DABRAFENIB | 100381565 |
| 200006474 | 200017873 | null | null | null | null | 2020-07-16 | null | null | null | IPILIMUMAB | 100330263 |
| 200006478 | 200017874 | 1.74 | 101 | Palliative (P) | 2016-07-27 | 2016-07-29 | null | 02 | null | IPILIMUMAB + NIVOLUMAB | 100814353 |
| 200006481 | 200017875 | 1.85 | 51.9 | Palliative (P) | null | 2019-02-16 | null | null | N | COLUMBUS TRIAL | 101526265 |
| 200006490 | 200017878 | null | 73.8 | Palliative (P) | 2020-01-24 | 2020-02-10 | Ipilimumab | 02 | N | IPILIMUMAB | 101102963 |
| 200006501 | 200017881 | 1.76 | null | null | null | 2017-07-21 | null | null | null | IPILIMUMAB | 100834433 |